Hi @zora0121, As you are well aware, KRAS is a tough mutation to treat. I've heard it described as 'slippery'. While more research is needed to help save lives, some of us don’t have time to wait for the treatments that we so desperately need. Being treated at a larger cancer center may be beneficial in your case with this rare mutation. Are you confident in the care you are receiving?
Others in the lung cancer group have mentioned G12D, and likely know much more than me, like @carlies or @campinggirl100.
Has your oncologist spoken to you about additional therapies; like the targeted therapy, sotorasib, or a combination therapy (sotorasib and immunotherapy or other)?